Treatment-resistant depression affects roughly one in three people diagnosed with major depressive disorder. These patients do not improve after trying multiple antidepressants, psychotherapy, or both. For clinicians and patients alike, this creates an urgent need for treatments that work faster and more reliably than traditional options. Ketamine has gained attention because it can reduce depressive symptoms within hours or days rather than weeks. However, its effects are often temporary, which has led researchers to explore ways to make improvements last longer.
Why Ketamine Alone Is Not Always Enough
Ketamine’s antidepressant effects are linked to rapid changes in glutamate signaling and synaptic plasticity in the brain. While this can quickly lift mood and reduce suicidal thinking, many patients experience symptom return once treatments stop. Repeated dosing can help, but it raises practical concerns related to cost, access, and long term treatment planning. These limitations have prompted interest in combining ketamine with psychotherapy to support longer lasting change.
What Is Ketamine-Assisted Psychotherapy
Ketamine-assisted psychotherapy, often called KAP, integrates ketamine administration with structured psychological support before, during, and after dosing sessions. The goal is to use ketamine’s unique mental state to help patients engage more deeply with therapy. During ketamine sessions, patients may experience reduced emotional rigidity, increased cognitive flexibility, and altered self perspective. Psychotherapy aims to help patients process these experiences and translate them into meaningful behavioral and emotional changes.
What the Latest Systematic Review Shows
A 2026 systematic review examined the effectiveness of ketamine-assisted psychotherapy for treatment-resistant depression by analyzing 11 studies that met strict inclusion criteria. Across these studies, patients receiving KAP generally showed reductions in depressive symptoms, with some improvements lasting up to six months. The studies fell into two broad categories: structured, protocol based approaches and more individualized, experiential models.
Importantly, among the few studies that included control groups, KAP did not consistently outperform comparison conditions. This highlights a major challenge in the field. Differences in ketamine dosing, psychotherapy style, session timing, and outcome measures make it difficult to draw firm conclusions. While results are encouraging, the evidence base remains limited.
How Psychotherapy May Enhance Ketamine’s Effects in Ketamine-Assisted Psychotherapy
Several proposed mechanisms explain why psychotherapy could strengthen ketamine’s benefits. Ketamine appears to temporarily disrupt rigid thought patterns that are common in chronic depression. Psychotherapy delivered during this window may help patients reframe negative beliefs, process emotional material, and practice new coping strategies.
Researchers also suggest that ketamine-induced neuroplasticity may make the brain more receptive to therapeutic learning, allowing insights gained in therapy to persist beyond the drug’s acute effects.
Safety and Clinical Considerations for Ketamine-Assisted Psychotherapy
From a safety standpoint, ketamine-assisted psychotherapy generally follows established medical ketamine protocols. Psychological preparation and integration sessions are critical, especially for patients who experience dissociation or emotional intensity during treatment. Clinicians must also carefully screen patients for conditions such as psychosis or uncontrolled substance use, where ketamine may not be appropriate.
What This Means for Patients and Clinicians
Ketamine-assisted psychotherapy represents a promising but still evolving approach for treatment-resistant depression. For patients who have not responded to standard care, KAP may offer symptom relief along with a therapeutic framework that supports longer term change. For clinicians, the current evidence underscores the importance of cautious optimism and individualized treatment planning.
Larger randomized controlled trials are still needed to determine who benefits most, which therapy models work best, and how durable outcomes truly are. Until then, ketamine-assisted psychotherapy should be viewed as an emerging option rather than a definitive solution.
Citations
Simpson RJ, Juruena MF. Effectiveness of ketamine-assisted psychotherapy as a treatment for treatment-resistant depression: a systematic review. Psychopharmacology. 2026. https://pubmed.ncbi.nlm.nih.gov/41652217/
Joneborg I, Lee Y, Di Vincenzo JD, et al. Active mechanisms of ketamine-assisted psychotherapy: a systematic review. Journal of Affective Disorders. 2022;315:105–112. https://pubmed.ncbi.nlm.nih.gov/35905796/